BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 9840417)

  • 1. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
    Zgombick JM; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
    Pauwels PJ; Palmier C
    Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.
    Dickenson JM; Hill SJ
    Br J Pharmacol; 1995 Dec; 116(7):2889-96. PubMed ID: 8680721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
    Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
    Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
    Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
    Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of the 5-HT1D receptor antagonist GR 127,935 at human 5-HT1D alpha, 5-HT1D beta, 5-HT1A and opossum 5-HT1B receptors.
    Pauwels PJ; Palmier C
    Eur J Pharmacol; 1995 Jul; 290(2):95-103. PubMed ID: 8575538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists.
    Unsworth CD; Molinoff PB
    Mol Pharmacol; 1992 Sep; 42(3):464-70. PubMed ID: 1328846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cloned human 5-HT1E receptor couples to inhibition and activation of adenylyl cyclase via two distinct pathways in transfected BS-C-1 cells.
    Adham N; Vaysse PJ; Weinshank RL; Branchek TA
    Neuropharmacology; 1994; 33(3-4):403-10. PubMed ID: 7984278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
    Hinton JM; Hill P; Jeremy J; Garland C
    J Vasc Res; 2000; 37(6):457-68. PubMed ID: 11146399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists.
    Albert PR; Sajedi N; Lemonde S; Ghahremani MH
    J Biol Chem; 1999 Dec; 274(50):35469-74. PubMed ID: 10585418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum.
    Murphy TJ; Bylund DB
    J Pharmacol Exp Ther; 1989 May; 249(2):535-43. PubMed ID: 2542534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor selectivity of the cloned opossum G protein-coupled receptor kinase 2 (GRK2) in intact opossum kidney cells: role in desensitization of endogenous alpha2C-adrenergic but not serotonin 1B receptors.
    Lembo PM; Ghahremani MH; Albert PR
    Mol Endocrinol; 1999 Jan; 13(1):138-47. PubMed ID: 9892019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems.
    Schoeffter P; Bobirnac I; Boddeke E; Hoyer D
    Neuropharmacology; 1997; 36(4-5):429-37. PubMed ID: 9225266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis toxin treatment prevents 5-HT(5a) receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells.
    Thomas EA; Matli JR; Hu JL; Carson MJ; Sutcliffe JG
    J Neurosci Res; 2000 Jul; 61(1):75-81. PubMed ID: 10861802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells.
    Schoeffter P; Bobirnac I
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):256-62. PubMed ID: 8584040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.
    Schoeffter P; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):285-92. PubMed ID: 2572975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.